Molecular and immunomodulatory actions of new antiasthmatic agents: exploring the diversity of biologics in Th2 endotype asthma
Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually. Until recently, the pharmacotherapy of severe asthma involved high doses of inhaled corticosteroids...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Academic Press
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/102223/ |